KIR3DL2 and mature T-cell and NK-cell non-Hodgkin lymphoma: Later research confirmed that KIR3DL2 is also upregulated in certain PTCL subtypes when assessed in vivo by either flow cytometric methods or immunohistochemistry, with highest rates of expression observed in PTCL-NOS and AITL [253].